Galera Therapeutics, Inc. Common Stock
GRTX
GRTX was delisted on the 3rd of June, 2024.
40 hedge funds and large institutions have $162M invested in Galera Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 8 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less funds holding
Funds holding: 47 → 40 (-7)
20% less capital invested
Capital invested by funds: $202M → $162M (-$39.7M)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$692K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$117K |
| 3 |
State Street
Boston,
Massachusetts
|
+$84.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$63.6K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$44.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.5M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.23M |
| 3 |
Millennium Management
New York
|
-$696K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$363K |
| 5 |
JP Morgan Chase
New York
|
-$308K |
GRTX Hedge Fund Activity: Q3 2021 in Review
40 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q3 2021, worth a combined $162M — down 20% from $202M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GRTX and 1 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 13 added.
The largest buyer was Altium Capital Management, adding an estimated $692K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.5M sold.
- 40 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q3 2021, down from 47 in Q2 2021.
- Funds reported $162M of Galera Therapeutics, Inc. Common Stock stock for Q3 2021, down 20% quarter-over-quarter.
- 1 fund opened new Galera Therapeutics, Inc. Common Stock positions in Q3 2021 and 8 closed out, a net change of -7 holders.
- The largest Galera Therapeutics, Inc. Common Stock buyer in Q3 2021 was Altium Capital Management, an estimated $692K added.
- The largest Galera Therapeutics, Inc. Common Stock seller in Q3 2021 was Perceptive Advisors, an estimated $2.5M sold.
Based on aggregated 13F filings for Q3 2021.